-
441
Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
Published 2018“…The NY-ESO-1-specific T cells response of the patient was found to be increased after the third and the fifth (**p = 0.002) cycles of treatment but had a significant decline after progression (**p = 0.0028). …”
-
442
Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction
Published 2021“…Efforts to develop effective treatments to protect pregnancies with abnormal UtA Dopplers would be of significant clinical benefit for mothers and their fetuses.…”
-
443
-
444
-
445
-
446
-
447
-
448
-
449
-
450
-
451
Exploring beyond numeric weight loss: The metabolic effects of semaglutide
Published 2025“…Semaglutide also slowed weight regain and promoted weight loss after failed <u>bariatric surgery.</u> It also significantly reduced ad libitum <u>energy intake</u>, decreased hunger, and increased satiety in multiple trials. …”
-
452
Downregulation of Lymphoid enhancer‐binding factor 1 (<i>LEF‐1)</i> expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophe...
Published 2020“…Absence of <i>LEF-1</i> expression in CLL/SLL is correlated (<i>P</i> < .05) with downregulation of CD5, CD23, CD200, expression of FMC7, brighter expression of CD79b, brighter expression of surface light chain, increased prolymphocytes and lower Matutes score.</p><h3>Conclusion</h3><p dir="ltr">As downregulation of <i>LEF-1</i> expression is well correlated with atypical CLL, we suggest adding <i>LEF-1</i> to Matutes score as a beneficial marker to differentiate classic from atypical CLL <i>LEF-1</i> could also serve as a potential prognostic indicator for CLL clinical course.…”
-
453
-
454
-
455
An overview of diabetes mellitus in pregnant women with obesity
Published 2024“…<p>Rates of obesity are increasing world-wide with an estimated 1billion people projected to be obese by 2030 if current trends remain unchanged. …”
-
456
-
457
-
458
-
459
-
460
MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM
Published 2020“…BC patients are oftentimes presented with lymph node metastasis (LNM), which increases their risk of recurrence. Compelling data have recently implicated microRNAs in promoting BC metastasis. …”